Patents by Inventor Paul Alexander Wilson

Paul Alexander Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases
    Publication number: 20140147435
    Abstract: The present invention relates to antibodies to NOGO, pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorders.
    Type: Application
    Filed: May 7, 2013
    Publication date: May 29, 2014
    Inventors: Jonathan Henry ELLIS, Paul Andrew Hamblin, Alan Peter Lewis, Paul Alexander Wilson
  • NOGO-a neutralising immunoglobulin for treatment of neurological diseases
    Patent number: 7988964
    Abstract: The present invention provides immunoglobulins, particularly antibodies that bind to NOGO and neutralise the activity thereof, polynucleotides encoding such antibodies, pharmaceutical formulations containing said antibodies and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases.
    Type: Grant
    Filed: December 20, 2004
    Date of Patent: August 2, 2011
    Assignee: Glaxo Group Limited
    Inventors: Jonathan Henry Ellis, Alexandre Eon-Duval, Robert Ian Grundy, Farhana Hussain, Ruth McAdam, Christopher Plumpton, Rabinder Kumar Prinjha, Paul Alexander Wilson
  • NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases
    Publication number: 20110054149
    Abstract: The present invention relates to antibodies to NOGO, pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorders.
    Type: Application
    Filed: August 23, 2010
    Publication date: March 3, 2011
    Inventors: JONATHAN HENRY ELLIS, PAUL ANDREW HAMBLIN, ALAN PETER LEWIS, PAUL ALEXANDER WILSON
  • Immunoglobulins which bind NOGO
    Patent number: 7780964
    Abstract: The present invention relates to antibodies to NOGO, pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorders.
    Type: Grant
    Filed: July 6, 2005
    Date of Patent: August 24, 2010
    Assignee: Glaxo Group Limited
    Inventors: Jonathan Henry Ellis, Paul Andrew Hamblin, Alan Peter Lewis, Paul Alexander Wilson